SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001372514-24-000095
Filing Date
2024-07-03
Accepted
2024-07-03 15:16:31
Documents
5
Period of Report
2024-07-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1720034184.html 3  
1 FORM 3 wk-form3_1720034184.xml 3 1664
2 EX-24.1 exhibit241_lisawalters-h.htm EX-24.1 6285
3 exhibit241_lisawalters-h001.jpg GRAPHIC 236410
4 exhibit241_lisawalters-h002.jpg GRAPHIC 111097
5 exhibit241_lisawalters-h003.jpg GRAPHIC 32849
  Complete submission text file 0001372514-24-000095.txt   533625
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Issuer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O DARE BIOSCIENCE, INC. 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121
Business Address
Walters-Hoffert Lisa (Reporting) CIK: 0001711576 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36672 | Film No.: 241099810